News & Events

Results of Operations and Financial Condition. On April 30, 2026, The Cigna Group issued a press release announcing results for the three months ended March 31, 2026. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities A…

Regulation FD Disclosure. The Company is reaffirming projected full year 2026 consolidated adjusted income from operations of at least $30.25 per share. The Company is also reaffirming 2026 Evernorth pre-tax adjusted income from operations of at least $6.9 billion, and Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion. The Cigna Group previously discussed its full year 2026 outlook in its press release dated February 5, 2026, and during the related investor con…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Executive Officer Succession On February 25, 2026, the Board of Directors (the “Board”) of The Cigna Group (the “Company”) appointed Mr. Brian C. Evanko as Chief Executive Officer (“CEO”) of the Company, effective July 1, 2026. Mr. Evanko will succeed Mr. David M. Cordani, who will retire as the CEO of the Company effective July 1, 2026. Mr.…

Regulation FD Disclosure. 2026 Outlook Affirmation The Cigna Group (or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2026 consolidated adjusted income from operations on a per share basis of at least $30.25 per share. The Cigna Group previously discussed its full year 2026 outlook in its press release dated February 5, 2026, and during the relat…

Results of Operations and Financial Condition. On February 5, 2026, The Cigna Group issued a press release announcing results for the three months and year ended December 31, 2025. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under th…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 15, 2025, Retired Major General Elder Granger, M.D. informed the Board of Directors (the “Board”) of The Cigna Group (the “Company”) that he will retire from the Board effective December 31, 2025. General Granger’s retirement is consistent with the Board’s retirement age policy. General Granger’s retirement is not the result of any disag…

Regulation FD Disclosure. 2025 Outlook Affirmation The Cigna Group (or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2025 consolidated adjusted income from operations on a per share basis of at least $29.60 per share. The Cigna Group previously discussed its full year 2025 outlook in its press release dated July 31, 2025, and during the related…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 2, 2025, The Cigna Group (the “Company”) filed a Current Report on Form 8-K announcing the action by the Company’s Board of Directors (the “Board”) on May 30, 2025 to appoint Michael J. Hennigan as an independent member of the Board, effective June 2, 2025. At the time of his appointment, the Board had not determined on which committees Mr.…

Regulation FD Disclosure. 2025 Outlook Affirmation The Cigna Group (or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2025 consolidated adjusted income from operations on a per share basis of at least $29.60 per share. The Cigna Group previously discussed its full year 2025 outlook in its press release and investor presentation dated May 2, 2025,…

Entry into a Material Definitive Agreement. On April 24, 2025, The Cigna Group (the “Company”) entered into a $6.5 billion Revolving Credit and Letter of Credit Agreement with the banks named therein, JPMorgan Chase Bank, N.A., as administrative agent, and BofA Securities, Inc., Citibank, N.A., Morgan Stanley Senior Funding, Inc. and Wells Fargo Securities, LLC, as joint lead arrangers and joint bookrunners (the “Credit Agreement”). The Credit Agreement replaces in full the Company’s existing…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in

Termination of a Material Definitive Agreement. The information set forth in

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 22, 2025, Ms. Noelle Eder, Executive Vice President, Global Chief Information Officer, The Cigna Group, resigned from the Company to pursue another opportunity, effective May 16, 2025. Ms. Eder’s decision to resign was due to personal reasons and was not a result of any disagreement with the Company.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 13, 2025, The Cigna Group (the “Company”) filed a Form 8-K disclosing that the employment of Eric P. Palmer, Executive Vice President for Enterprise Strategy, The Cigna Group and President and Chief Executive Officer, Evernorth Health Services, will end April 26, 2025. On April 15, 2025, the Company and Mr. Palmer executed an Agreement and…

Regulation FD Disclosure. The Company is reaffirming projected full year 2025 consolidated adjusted income from operations of at least $29.50 per share. The Company is also reaffirming 2025 Evernorth pre-tax adjusted income from operations of at least $7.2 billion, and Cigna Healthcare pre-tax adjusted income from operations of at least $4.1 billion. The Cigna Group previously discussed its full year 2025 outlook in its press release and investor presentation dated January 30, 2025, and durin…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 13, 2025, The Cigna Group (the “Company”) announced certain leadership changes. Among these changes, effective March 31, 2025, Brian C. Evanko will serve as President and Chief Operating Officer, The Cigna Group and Ann M. Dennison will serve as Executive Vice President, Chief Financial Officer, The Cigna Group. Mr. Evanko, 48, has served…

Regulation FD Disclosure. 2025 Outlook Affirmation The Cigna Group (or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2025 consolidated adjusted income from operations on a per share basis of at least $29.50 per share. The Cigna Group previously discussed its full year 2025 outlook in its press release and investor presentation dated January 30,…

Regulation FD Disclosure. 2024 Outlook Affirmation The Cigna Group (the “Company” or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2024 consolidated adjusted income from operations on a per share basis of at least $28.40 per share. The Cigna Group previously discussed its full year 2024 outlook in its press release and investor presentation date…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 14, 2024, The Cigna Group (the “Company” or “our”) appointed Jamie Kates as the Company’s Chief Accounting Officer, serving as the Company’s principal accounting officer, effective July 1, 2024. Ms. Kates, 44, has served as Vice President, Accounting, since October 2021, pursuant to which she managed the Evernorth Health Services accounting…

Regulation FD Disclosure. 2024 Outlook Affirmation The Cigna Group (the “Company” or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2024 consolidated adjusted income from operations on a per share basis of at least $28.40 per share. Additionally, the Company recently completed the previously announced accelerated share repurchase agreements to pu…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 16, 2024, Mary Agoglia Hoeltzel, Senior Vice President and Chief Accounting Officer, notified The Cigna Group of her intention to retire, effective July 1, 2024. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 17, 2024, The Cigna Group (the “Company”) announced certain organizational changes. Among these changes, effective February 5, 2024: · Brian C. Evanko will serve as President and Chief Executive Officer, Cigna Healthcare, in addition to his current role as Executive Vice President and Chief Financial Officer, The Cigna Group. · Eric P. P…

Regulation FD Disclosure. 2023 Outlook Affirmation The Cigna Group (the “Company” or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2023 consolidated adjusted income from operations on a per share basis of at least $24.75 per share and targeted consolidated adjusted income from operations on a per share basis of at least $28.00 for full-year 2024…

Regulation FD Disclosure. 2023 Outlook Affirmation The Cigna Group (the “Company” or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2023 consolidated adjusted income from operations on a per share basis of at least $24.75 per share. The Cigna Group previously discussed its full year 2023 outlook in its press release and investor presentation date…

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 14, 2023, The Cigna Group (the “Company”) approved compensation changes for Noelle K. Eder and Nicole S. Jones to reflect expansion of their roles and responsibilities. Ms. Eder, Executive Vice President, Technology and Operations, now leads the new Technology and Operations function , and Ms. Jones, Executive Vice President, Chief Adm…